These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37006269)

  • 1. Type I interferon score is associated with the severity and poor prognosis in anti-MDA5 antibody-positive dermatomyositis patients.
    Qian J; Li R; Chen Z; Cao Z; Lu L; Fu Q
    Front Immunol; 2023; 14():1151695. PubMed ID: 37006269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical characteristics of subcutaneous and mediastinal emphysema in anti-melanoma differentiation-associated 5 positive dermatomyositis associated with interstitial lung disease.
    Huang W; Chen D; Ren F; Luo L; Zhou J; Huang D; Tian M; Qian K; Jiang Y; Tang L
    Clin Exp Rheumatol; 2024 Feb; 42(2):262-268. PubMed ID: 38147317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies.
    Shao C; Xia N; Zhen Y; Zhang X; Yan N; Guo Q
    Front Immunol; 2024; 15():1404828. PubMed ID: 38745647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases.
    Allenbach Y; Uzunhan Y; Toquet S; Leroux G; Gallay L; Marquet A; Meyer A; Guillaud C; Limal N; Gagnadoux F; Hervier B; Borie R; Deligny C; Terrier B; Berezne A; Audia S; Champtiaux N; Devilliers H; Voermans N; Diot E; Servettaz A; Marhadour T; Castelain V; Humbert S; Blanchard-Delaunay C; Tieulie N; Charles P; Gerin M; Mekinian A; Priou P; Meurice JC; Tazi A; Cottin V; Miyara M; Grange B; Israël-Biet D; Phin-Huynh S; Bron C; De Saint Martin L; Fabien N; Mariampillai K; Nunes H; Benveniste O;
    Neurology; 2020 Jul; 95(1):e70-e78. PubMed ID: 32487712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell landscape of peripheral immune response in patients with anti-melanoma differentiation-associated gene 5 dermatomyositis.
    He J; Liu Z; Cao Y; Zhang X; Yi C; Zhou Y; Yang C; Guo Z; Zheng Q; Huang J
    Rheumatology (Oxford); 2024 Aug; 63(8):2284-2294. PubMed ID: 37941459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of exhausted CD8+ T cells associates with increased pulmonary fungal infection risk in anti-melanoma differentiation associated gene 5 dermatomyositis.
    Xu YT; Cao ZY; Lin S; Shu XM; Lu X; Wang GC; Peng QL
    Clin Exp Rheumatol; 2024 Feb; 42(2):237-245. PubMed ID: 38153165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: Prevalence, risk factors, and prognosis.
    Jin Q; Lin S; Chen X; Xu Y; Tian X; He L; Jiang W; Chen F; Shu X; Lu X; Peng Q; Wang G
    Semin Arthritis Rheum; 2024 Apr; 65():152352. PubMed ID: 38185078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between B-cell epitope profile and clinical features of anti-MDA5 antibody-positive dermatomyositis.
    Yamaguchi K; Poland P; Bijoy George T; Saygin D; Moghadam-Kia S; Aggarwal R; Oddis CV; Zhu L; Ascherman DP
    Rheumatology (Oxford); 2024 Jul; 63(7):2016-2023. PubMed ID: 37815819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nintedanib could potentially lead to improvements in anti-melanoma differentiation-associated 5 dermatomyositis-associated interstitial lung disease.
    Chen X; Jiang W; Jin Q; Lin S; Zhang L; Peng Q; Sun H; Wang Y; Lu X; Song A; Wang G; Ge Y
    Clin Exp Rheumatol; 2024 Feb; 42(2):386-393. PubMed ID: 38153137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with macrophage activation syndrome.
    Yang L; Zhang P; Yang Q; Zhang C; Guan W; Liu S
    Clin Exp Rheumatol; 2024 Feb; 42(2):269-276. PubMed ID: 38147318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against the melanoma differentiation-associated protein 5 in patients with dermatomyositis target the helicase domains.
    Van Gompel E; Demirdal D; Fernandes-Cerqueira C; Horuluoglu B; Galindo-Feria A; Wigren E; Gräslund S; De Langhe E; Benveniste O; Notarnicola A; Chemin K; Lundberg IE
    Rheumatology (Oxford); 2024 May; 63(5):1466-1473. PubMed ID: 37572295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-associated immune cell endotypes in anti-MDA5-positive dermatomyositis using unbiased hierarchical clustering.
    Guo R; Yang Y; Gu L; Li X; Ma Y; Liu X; Lu L
    Front Immunol; 2024; 15():1349611. PubMed ID: 38533498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of mortality for dermatomyositis patients positive with anti-melanoma differentiation-related gene 5 and optimal treatment.
    Liu L; Zhang Y; Shu X; Wang C; Guan W; Zhang X; Zhang L; Liu X; Wang L; Liu S; Li T
    Clin Exp Rheumatol; 2024 Feb; 42(2):246-252. PubMed ID: 37199165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate logistic regression analysis of poor prognosis of dermatomyositis and clinical value of ferritin/Kl-6 in predicting prognosis.
    Yan L; Shi Y; Wu C; Li Y
    Skin Res Technol; 2024 May; 30(5):e13701. PubMed ID: 38682785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDA5-autoimmunity and Interstitial Pneumonitis Contemporaneous with the COVID-19 Pandemic (MIP-C).
    Iqbal K; Sinha S; David P; De Marco G; Taheri S; McLaren E; Maisuria S; Arumugakani G; Ash Z; Buckley C; Coles L; Hettiarachchi C; Smithson G; Slade M; Shah R; Marzo-Ortega H; Keen M; Lawson C; Mclorinan J; Nizam S; Reddy H; Sharif O; Sultan S; Tran G; Wood M; Wood S; Ghosh P; McGonagle D
    medRxiv; 2023 Nov; ():. PubMed ID: 37961408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and immunological features of COVID-19 in patients with anti-MDA5 dermatomyositis during the omicron wave in Chongqing, China.
    Wu N; Chen Z; Zha G; Deng Z; Huang W; Cai D; Peng M; Hu P; Tang L; Ren H
    J Med Virol; 2024 Mar; 96(3):e29493. PubMed ID: 38436114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated liver enzymes: unusual presentation of anti-MDA5 antibody-associated juvenile dermatomyositis.
    Yi BY; Marrs J; Schenker R; Suddock J; Cotter JA; Cidon M
    Clin Exp Rheumatol; 2024 Feb; 42(2):456-457. PubMed ID: 37279157
    [No Abstract]   [Full Text] [Related]  

  • 18. From machine learning to clinical practice: phenotypic clusters of anti-MDA5 antibody-positive dermatomyositis.
    Koopman JJE; Buhler KA; Choi MY
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38920344
    [No Abstract]   [Full Text] [Related]  

  • 19. Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies.
    Hosono Y; Sie B; Pinal-Fernandez I; Pak K; Mecoli CA; Casal-Dominguez M; Warner BM; Kaplan MJ; Albayda J; Danoff S; Lloyd TE; Paik JJ; Tiniakou E; Aggarwal R; Oddis CV; Moghadam-Kia S; Carmona-Rivera C; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Christopher-Stine L; Larman HB; Mammen AL
    Ann Rheum Dis; 2023 Feb; 82(2):246-252. PubMed ID: 36008132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, Risk Factors, and Mortality of Invasive Pulmonary Aspergillosis in Patients with Anti-MDA5+ Dermatomyositis: A Retrospective Study in China.
    Chen X; Lin S; Jin Q; Zhang L; Jiang W; Lu X; Wang G; Ge Y
    J Inflamm Res; 2024; 17():3247-3257. PubMed ID: 38800596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.